UNSPSC 51151643: Hexocyclium

This classification denotes an antimuscarinic agent with the molecular formula C20H33N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LL3147PI1T. European Medicines Agency schedules hexocyclium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02515MIG. HEXOCYCLIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HEXOCYCLIUM remains the US FDA Preferred Term for this commodity.

Hexocyclium bears US NLM identifiers UMLS ID C0062674 and NCI Concept Code C78074. SMILES: OC(C1CCCCC1)(CN1CC[N](CC1)(C)C)C1CCCCC1..

UNSPSC 51151643 Hexocyclium, a Commodity code, describes pharmaceutical products that state and local governments procure for health and safety initiatives, though recent activity shows a mismatch between the nominal code scope and actual purchasing patterns. The single recent opportunity substantively related to the code is Seminole County, Florida's IFB for naloxone and safe drug deactivation systems—products aimed at opioid overdose response and controlled substance management in community health settings. A second state-level posting from Texas Health and Human Services Commission tagged to this code is an RFI on direct-to-manufacturer prescription program capabilities, which addresses pharmacy benefit program design rather than hexocyclium procurement and appears misclassified. Health departments and public health agencies are the primary issuing bodies when genuine procurement under this code occurs, though the overall volume of state and local solicitations tagged to hexocyclium is sparse.

The code shows minimal recent activity concentrated in the Southeast. Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023 (an apparent data inconsistency in the source), requests annual delivery of 1,900 naloxone units and 800 drug deactivation systems through quarterly shipments to Seminole County Community Health Building in Sanford, with a two-year initial term and one-year renewal option on a fixed-fee basis; vendors must provide delivery costs, maintain standard insurance coverage, pass E-Verify verification, and comply with FEMA-related federal environmental requirements. The Texas RFI represents exploratory market research on pharmacy contracting models rather than a hardware or pharmaceutical commodity purchase and does not reflect substantive hexocyclium demand. No other state or local opportunities matching the code's nominal scope appear in the recent record.